ZENSUN ENT (00185.HK) announced its full-year results for the year ended last December, with a revenue of RMB 6.917 billion, a year-on-year decrease of 27.5%. The loss narrowed to RMB 856 million, compared to a loss of RMB 2.182 billion in the same period last year; the loss per share was 44.7 cents. No dividend was declared